셀룰라이트 치료 시장 : 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Cellulite Treatment Market was valued at USD 2.4 billion in 2024 and is estimated to grow at a CAGR of 10.7% to reach USD 6.5 billion by 2034, driven by the increasing popularity of advanced non-invasive and minimally invasive treatments, which offer consumers more effective solutions with minimal downtime. Additionally, heightened consumer awareness regarding body aesthetics and the desire for safer, less invasive treatments have further fueled the demand for these procedures. Cellulite is a widespread cosmetic concern, commonly seen around the thighs, hips, and abdomen, resulting in the appearance of dimpled or lumpy skin. It primarily affects women and can be triggered or worsened by various factors, such as aging, hormonal imbalances, and weight gain.

Additionally, lifestyle factors like a sedentary routine, poor diet, and insufficient circulation can contribute to its development. As cellulite forms when fat deposits push through the connective tissue beneath the skin, it creates an uneven surface appearance. With the rising incidence of cellulite, especially among those affected by obesity and the aging process, there is an increased demand for effective treatments that can reduce its visibility and restore smoother, firmer skin. Treatments that focus on breaking down fat cells, stimulating blood flow, and boosting collagen production are gaining popularity. These treatments aim to reshape the fat distribution beneath the skin, improving the overall texture and tone of the affected areas.

The market is primarily segmented into various treatment types, including non-invasive, minimally invasive, and topical treatments. Among these, the non-invasive segment holds the largest market share, projected to grow at a CAGR of 11.1%, reaching USD 3.2 billion by 2034. These non-surgical treatments, such as laser therapy, acoustic wave therapy, radiofrequency therapy, and ultrasound therapy, are highly favored due to their painless nature, ease of use, and rapid recovery times. They provide a preferred option for individuals looking to minimize cellulite without undergoing extensive procedures. The non-invasive treatments continue to evolve, with companies focusing on improving these methods to meet increasing consumer demand for effective, comfortable, and low-risk solutions.

The hard cellulite segment was valued at USD 1.1 billion in 2024 and is expected to reach USD 3 billion by 2034, growing at a CAGR of 10.4%. Hard cellulite, which is characterized by dense, fibrous tissue and is more resistant to traditional treatments, requires more advanced treatment methods, such as laser therapy and radiofrequency. The increasing prevalence of hard cellulite among younger individuals who lead active lifestyles has driven demand for these specialized treatments. This has led to a surge in the development of innovative and effective therapies aimed at addressing this more stubborn form of cellulite.

U.S. Cellulite Treatment Market was valued at USD 763.7 million in 2024, attributed to the high occurrence of cellulite in the population, the growing awareness of available treatments, and the strong preference for non-invasive options. Furthermore, the U.S. benefits from a well-established healthcare infrastructure and a focus on cosmetic and aesthetic treatments, which have boosted the demand for cellulite reduction therapies.

Companies in the Global Cellulite Treatment Market are adopting strategies such as product innovation, partnerships, and expanding their geographic presence to strengthen their market position. Firms like Venus Concept, Soliton (AbbVie), and Cynosure are focusing on enhancing their product offerings with cutting-edge technology to meet the growing demand for effective treatments. Collaborations with healthcare providers and cosmetic clinics, along with strategic marketing campaigns, have enabled these companies to expand their reach. Additionally, they are investing in research and development to create more advanced and efficient cellulite treatments, ensuring they maintain a competitive edge in the market.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing awareness and demand for aesthetic procedures
    • 3.2.1.2 Growing advancement in non-invasive and minimally invasive technologies
    • 3.2.1.3 Increasing preference for non-invasive and minimally invasive procedures
    • 3.2.1.4 Expansion of dermatology and aesthetic clinics
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High treatment costs
    • 3.2.2.2 Growing concerns related to potential side effects
    • 3.2.2.3 Strict regulatory approvals
• 3.3 Growth potential analysis
• 3.4 Pipeline analysis
• 3.5 Technology landscape
• 3.6 Regulatory landscape
• 3.7 Trump administration tariffs
  • 3.7.1 Impact on trade
    • 3.7.1.1 Trade volume disruptions
    • 3.7.1.2 Retaliatory measures
  • 3.7.2 Impact on the Industry
    • 3.7.2.1 Supply-side impact (raw materials)
      • 3.7.2.1.1 Price volatility in key materials
      • 3.7.2.1.2 Supply chain restructuring
      • 3.7.2.1.3 Production cost implications
    • 3.7.2.2 Demand-side impact (selling price)
      • 3.7.2.2.1 Price transmission to end markets
      • 3.7.2.2.2 Market share dynamics
      • 3.7.2.2.3 Consumer response patterns
  • 3.7.3 Key companies impacted
  • 3.7.4 Strategic industry responses
    • 3.7.4.1 Supply chain reconfiguration
    • 3.7.4.2 Pricing and product strategies
    • 3.7.4.3 Policy engagement
  • 3.7.5 Outlook and future considerations
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Cellulite Type, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Hard cellulite
• 5.3 Soft cellulite
• 5.4 Edematous cellulite

Chapter 6 Market Estimates and Forecast, By Treatment Type, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Non-invasive treatment
  • 6.2.1 Laser treatment
  • 6.2.2 Acoustic wave therapy
  • 6.2.3 Radiofrequency therapy
  • 6.2.4 Ultrasound therapy
• 6.3 Minimally invasive treatment
  • 6.3.1 Subcision
  • 6.3.2 Cryolipolysis
  • 6.3.3 Other minimally invasive treatment
• 6.4 Topical treatments
• 6.5 Oral supplements

Chapter 7 Market Estimates and Forecast, By Gender, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Female
• 7.3 Male

Chapter 8 Market Estimates and Forecast, By Age Group, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Below 30 years
• 8.3 30 - 50 years
• 8.4 Above 50 years

Chapter 9 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 Hospitals
• 9.3 Dermatology clinics
• 9.4 Beauty and wellness centers
• 9.5 Home-use

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Netherlands
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 India
  • 10.4.3 Japan
  • 10.4.4 Australia
  • 10.4.5 South Korea
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Argentina
• 10.6 Middle East and Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 UAE

Chapter 11 Company Profiles

• 11.1 Air Sculpt
• 11.2 Alma Lasers
• 11.3 Bausch Health
• 11.4 Bionov
• 11.5 Candela
• 11.6 Cutera
• 11.7 Cynosure
• 11.8 El En. Group
• 11.9 Endo International
• 11.10 Hologic
• 11.11 Merz Pharma
• 11.12 Mesoestetic
• 11.13 Revelle Aesthetics
• 11.14 Sirona Biochem
• 11.15 Soliton (Abbvie)
• 11.16 Ulthera
• 11.17 Zimmer Aesthetics